GRMLW

MKT CAP:$15M

Greenland Mines Ltd

Market Cap

$15M

Basic Materials·Other Precious Metals·🇺🇸 United States·NASDAQ

Materials·Other·🇺🇸·NASDAQ

Stock Price

$0.18+$0.10 (+139.36%)

Apr 20, 2026

Company Details

Greenland Mines Ltd. engages in the provision of new therapies to treat neurodegenerative diseases. It offers cell and gene therapy. The company was founded by Joseph Sinkule on August 2, 2004 and is headquartered in Omaha, NE.

CEO

Joseph A. Sinkule

IPO Date

Apr 29, 2022

Website

greenlandmines.com

Key Metrics TTM

Revenue

$0

— YoY

Net Income

-$11M

EPS (Diluted)

-$0.33

Free Cash Flow

-$6M

Revenue / Share

$0.00

Gross Margin

—

Operating Margin

—

Net Margin

—

FCF Margin

—

P/S

—

P/E

—

Earnings Reports

Q3 2025

Sep 29, 2025

$0EPS -$0.05

Q2 2025

Jun 29, 2025

$0EPS -$0.12

Q1 2025

Mar 30, 2025

$0EPS -$0.08

FY 2024

Dec 30, 2024

$0EPS -$0.32

Q4 2024

Dec 30, 2024

$0EPS -$0.08

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q2 22	$0	$0	-$232.7K
Q3 22	$0	$0	-$179.7K
Q4 22	$0	$0	-$239.5K
Q1 23	$0	$0	-$325.8K
Q2 23	$0	$0	-$244.3K
Q3 23	$0	$0	-$123.7K
Q4 23	$0	$0	-$110.7K
Q1 24	$0	$0	-$422.0K
Q2 24	$0	$0	-$395.6K
Q3 24	$0	$0	-$3M
Q4 24	$0	$0	-$2M
Q1 25	$0	$0	-$2M
Q2 25	$0	$0	-$2M
Q3 25	$0	$0	-$2M

Valuation

Quarter	P/S	P/E
Q2 22	—	—
Q3 22	—	—
Q4 22	—	—
Q1 23	—	2.5x
Q2 23	—	2.6x
Q3 23	—	4.2x
Q4 23	—	10.2x
Q1 24	—	—
Q2 24	—	—
Q3 24	—	—
Q4 24	—	—
Q1 25	—	—
Q2 25	—	—
Q3 25	—	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	$6.3K	$6.3K
Q2 22	-$392.9K	-$392.9K
Q1 23	-$373.0K	-$373.0K
Q2 23	$107.5K	$107.5K
Q3 23	-$27.0K	-$27.0K
Q4 23	-$313.5K	-$313.5K
Q1 24	-$72.0K	-$72.0K
Q2 24	-$424.9K	-$424.9K
Q3 24	-$1M	-$1M
Q4 24	-$944.2K	-$944.1K
Q1 25	-$2M	-$2M
Q2 25	-$2M	-$2M
Q3 25	-$1M	-$1M

Capital Expenditures

Quarter	CapEx
Q1 22	$0
Q2 22	$3
Q1 23	$3
Q2 23	$0
Q3 23	$3
Q4 23	$0
Q1 24	$4
Q2 24	$3
Q3 24	$0
Q4 24	$4
Q1 25	$3
Q2 25	$0
Q3 25	$0

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q2 23	—	+4.9%
Q3 23	—	-31.2%
Q4 23	—	-53.8%
Q1 24	—	+29.6%
Q2 24	—	+62.0%
Q3 24	—	+2220.2%
Q4 24	—	+1572.2%
Q1 25	—	+276.0%
Q2 25	—	+378.5%
Q3 25	—	-35.4%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$0	—
Q2 22	$0	—
Q1 23	$0	—
Q2 23	$0	—
Q3 23	$0	—
Q4 23	$0	—
Q1 24	$0	—
Q2 24	$0	—
Q3 24	$0	—
Q4 24	$0	—
Q1 25	$0	—
Q2 25	$0	—
Q3 25	$0	—

OpEx Breakdown

Quarter	R&D	SG&A
Q2 22	—	$193.4K
Q3 22	—	$140.4K
Q4 22	—	$195.3K
Q1 23	—	$293.7K
Q2 23	—	$244.3K
Q3 23	—	$123.7K
Q4 23	—	$110.7K
Q1 24	—	$672.0K
Q2 24	—	$395.6K
Q3 24	—	$3M
Q4 24	—	$2M
Q1 25	—	$2M
Q2 25	$238.7K	$2M
Q3 25	$271.1K	$2M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$6.7K	$0	$6.7K
Q2 22	$447.4K	$0	$447.4K
Q3 22	$414.1K	$0	$414.1K
Q4 22	$341.0K	$0	$341.0K
Q1 23	$118.0K	$0	$118.0K
Q2 23	$123.7K	$0	$123.7K
Q3 23	$146.3K	$0	$146.3K
Q4 23	$2.8K	$0	$2.8K
Q1 24	$8.1K	$0	$8.1K
Q2 24	$845.3K	$0	$845.3K
Q3 24	$50.9K	$0	$50.9K
Q4 24	$63.7K	$0	$63.7K
Q1 25	$565.9K	$0	$565.9K
Q2 25	$8M	$0	$8M
Q3 25	$7M	$0	$7M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q2 22	15M	—	—
Q3 22	15M	0.0%	—
Q4 22	15M	0.0%	—
Q1 23	15M	-0.9%	—
Q2 23	15M	+2.4%	+1.5%
Q3 23	15M	0.0%	+1.5%
Q4 23	15M	0.0%	+1.5%
Q1 24	15M	0.0%	+2.4%
Q2 24	16M	+3.6%	+3.6%
Q3 24	17M	+6.4%	+10.3%
Q4 24	27M	+62.3%	+79.0%
Q1 25	28M	+1.6%	+81.9%
Q2 25	34M	+23.4%	+116.5%
Q3 25	59M	+75.0%	+256.0%

Shares Outstanding